RSV vaccine for pregnant people with HIV
Treatments studied
Part of Immune system & allergy, Infections, Women’s health & pregnancy clinical trials.
This study tests a vaccine (called RSVpreF) for pregnant people living with HIV. The vaccine is meant to boost your own immunity so you can pass protection to your baby against RSV, a common and sometimes dangerous respiratory infection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 19 years old and pregnant.
- You must have HIV.
- Between 28 and 34 weeks into your pregnancy at the start, so you can get the vaccine at 32-36 weeks.
- Be able to bring your baby for a follow-up visit in person at the Oak Tree Clinic.
- No severe allergies to vaccines and no recent use of certain immune blood products.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests two approved ways to prevent RSV, a common virus that can make babies very sick. Pregnant women may get a vaccine, and/or their babies may get an antibody shot after birth. The study compares these options to see which works best.
This trial tests giving a medicine called nirsevimab to newborns and a possible vaccine to pregnant mothers to prevent RSV, a serious lung infection in babies. It checks if combining both is safe and works better than nirsevimab alone.
This study tests an approved RSV vaccine given to pregnant women. The goal is to see if it safely protects their babies from severe RSV lung infections during the first months of life.
This registry follows pregnant people who received an RSV vaccine during a specific window (32 to 36 weeks) to monitor safety. If you got the shot in that time, your information helps researchers understand how well the vaccine works in pregnancy.
This study tests whether a second dose of the RSV vaccine during a new pregnancy protects you and your baby from RSV. If you received the RSVpreF or Abrysvo vaccine in a past pregnancy, you may be able to join.
This study looks at how well the RSV vaccine given to pregnant women (called ABRYSVO) protects babies from getting RSV after birth. It uses national health data from Scotland to track health outcomes.
Hear when a new RSV Immunization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.